CFO Barry Steele buys 7,000 shares as stock trades well below 52-week high; repeat buyer with mixed prior timing.
Barry Steele, the company's Executive VP and CFO, is making his fourth open-market purchase in the past three years, adding 7,000 shares while InfuSystem's stock trades roughly one-fifth below its 52-week high and has declined over the past month. The company is profitable with growing revenue, making this a financially healthy backdrop for an insider purchase at a lower price point. However, Steele's prior three purchases at this stock show mixed results: two of them were well-timed and saw the stock rise afterward, but one recent buy in early March saw the stock decline in the following months, suggesting his timing has not been consistently reliable. This current purchase notably comes while the stock is in relative weakness, a pattern often associated with insider confidence, though his recent track record at this ticker warrants watching to see whether this trade proves to be well-timed or repeats the more recent miss.